Theorem Clinical Research

King Of Prussia, United States Founded: 1985 • Age: 41 yrs Acquired By Chiltern International
Clinical development services for biopharma and medical devices are provided.

About Theorem Clinical Research

Theorem Clinical Research is a Healthcare company based in King Of Prussia (United States) founded in 1985, and was acquired by Chiltern International in August 2015. Clinical development services for biopharma and medical devices are provided. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its competitors include Celgene, Syneos Health and Medelis WCCT Global; 2 of its 3 listed competitors have raised funding.

Company details

The company was offering clinical development services, such as clinical trial management, clinical monitoring, clinical quality assurance, and medical monitoring and clinical analytics services, including clinical data management, medical writing, and biometrics services. In addition, the company offered clinical support services, such as TrialShare, a secure study-and project-specific Web portal that enables data sharing and collaboration; Theorem Clinical Research Inc. had strategic alliances with companies like Charles River, Decision Driver Analytics, Biomedical Systems, Ximedica etc, . It had expertise in development of medical devices and diagnostics, and also in clinical analytics and clinical supplies. It was acquired by Chiltern, a UK based CRO, in September 2015.

Key Metrics

Investors in Theorem Clinical Research

Theorem Clinical Research has secured backing from 1 investor. Prominent investors backing the company include Chiltern International.

All
InvestorDescriptionFounded YearDomainLocation
Full service CRO with expertise in oncology related development services
1982chiltern.comBerkshire County, United States
Premium access

Investor details for Theorem Clinical Research

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Theorem Clinical Research

2 dated milestones of Theorem Clinical Research across 30 years, from founding to its latest funding, stage changes and deals.

  1. Founded Theorem Clinical Research is founded.
  2. Exit Acquired by Chiltern International.

Competitors of Theorem Clinical Research

Theorem Clinical Research has 3 listed competitors in our database, 2 of them funded. They include Celgene, Syneos Health and Medelis WCCT Global.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
celgene.com1986Summit, United States$45M4,891
Therapies for cancer and inflammatory diseases are developed.
syneoshealth.com1984Raleigh, United States29,395
CRO clinical development services are provided by Syneos Health.
wcct.com1998Cypress, United States$17M229
Full-service CRO expertise in influenza and oncology research is offered.
Premium access

Detailed competitors of Theorem Clinical Research

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Theorem Clinical Research

Websites that share an audience with Theorem Clinical Research (theoremclinical.com).

Similar websites

Websites whose visitors overlap most with Theorem Clinical Research. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
aptivsolutions.com
100%
View details
premier-research.com
96%
39.9K#825,378View details
indeed.com
69%
416.4M#70View details

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Theorem Clinical Research (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Theorem Clinical Research

Theorem Clinical Research was founded in 1985.

Theorem Clinical Research is headquartered in King Of Prussia, United States. It is registered at King Of Prussia, Pennsylvania, United States.

The company was offering clinical development services, such as clinical trial management, clinical monitoring, clinical quality assurance, and medical monitoring and clinical analytics services, including clinical data management, medical writing, and biometrics services. In addition, the company offered clinical support services, such as TrialShare, a secure study-and project-specific Web portal that enables data sharing and collaboration; Theorem Clinical Research Inc. had strategic alliances with companies like Charles River, Decision Driver Analytics, Biomedical Systems, Ximedica etc, . It had expertise in development of medical devices and diagnostics, and also in clinical analytics and clinical supplies. It was acquired by Chiltern, a UK based CRO, in September 2015.

Theorem Clinical Research's top competitors include Syneos Health, Medelis WCCT Global and Celgene.

Theorem Clinical Research has 1 investor. Key investors include Chiltern International.

Yes. Theorem Clinical Research was acquired by Chiltern International in August 2015.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available